160 related articles for article (PubMed ID: 38278977)
21.
Chen T; Ding R; Chen X; Lu Y; Shi J; Lü Y; Tang B; Zhang W; Ye C; Yuan M; Yang Z
Bioengineered; 2021 Dec; 12(1):8233-8246. PubMed ID: 34592890
[TBL] [Abstract][Full Text] [Related]
22. Serum DKK1 as a protein biomarker for the diagnosis of hepatocellular carcinoma: a large-scale, multicentre study.
Shen Q; Fan J; Yang XR; Tan Y; Zhao W; Xu Y; Wang N; Niu Y; Wu Z; Zhou J; Qiu SJ; Shi YH; Yu B; Tang N; Chu W; Wang M; Wu J; Zhang Z; Yang S; Gu J; Wang H; Qin W
Lancet Oncol; 2012 Aug; 13(8):817-26. PubMed ID: 22738799
[TBL] [Abstract][Full Text] [Related]
23. Characteristics of the Urinary Microbiome From Patients With Gout: A Prospective Study.
Ning Y; Yang G; Chen Y; Zhao X; Qian H; Liu Y; Chen S; Shi G
Front Endocrinol (Lausanne); 2020; 11():272. PubMed ID: 32508748
[TBL] [Abstract][Full Text] [Related]
24. Microbiome Signatures Associated With Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.
Schwimmer JB; Johnson JS; Angeles JE; Behling C; Belt PH; Borecki I; Bross C; Durelle J; Goyal NP; Hamilton G; Holtz ML; Lavine JE; Mitreva M; Newton KP; Pan A; Simpson PM; Sirlin CB; Sodergren E; Tyagi R; Yates KP; Weinstock GM; Salzman NH
Gastroenterology; 2019 Oct; 157(4):1109-1122. PubMed ID: 31255652
[TBL] [Abstract][Full Text] [Related]
25. Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling.
Li Z; Zhang Y; Hong W; Wang B; Chen Y; Yang P; Zhou J; Fan J; Zeng Z; Du S
Gut Microbes; 2022; 14(1):2119055. PubMed ID: 36093568
[TBL] [Abstract][Full Text] [Related]
26. Gut microbial dysbiosis associates hepatocellular carcinoma via the gut-liver axis.
Jiang JW; Chen XH; Ren Z; Zheng SS
Hepatobiliary Pancreat Dis Int; 2019 Feb; 18(1):19-27. PubMed ID: 30527903
[TBL] [Abstract][Full Text] [Related]
27. A gut bacterial signature in blood and liver tissue characterizes cirrhosis and hepatocellular carcinoma.
Effenberger M; Waschina S; Bronowski C; Sturm G; Tassiello O; Sommer F; Zollner A; Watschinger C; Grabherr F; Gstir R; Grander C; Enrich B; Bale R; Putzer D; Djanani A; Moschen AR; Zoller H; Rupp J; Schreiber S; Burcelin R; Lass-Flörl C; Trajanoski Z; Oberhuber G; Rosenstiel P; Adolph TE; Aden K; Tilg H
Hepatol Commun; 2023 Jul; 7(7):. PubMed ID: 37314752
[TBL] [Abstract][Full Text] [Related]
28. Discovering Biomarkers for Non-Alcoholic Steatohepatitis Patients with and without Hepatocellular Carcinoma Using Fecal Metaproteomics.
Sydor S; Dandyk C; Schwerdt J; Manka P; Benndorf D; Lehmann T; Schallert K; Wolf M; Reichl U; Canbay A; Bechmann LP; Heyer R
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012106
[TBL] [Abstract][Full Text] [Related]
29. A blood-based three-gene signature for the non-invasive detection of early human hepatocellular carcinoma.
Shi M; Chen MS; Sekar K; Tan CK; Ooi LL; Hui KM
Eur J Cancer; 2014 Mar; 50(5):928-36. PubMed ID: 24332572
[TBL] [Abstract][Full Text] [Related]
30. Identification of noninvasive diagnostic biomarkers for hepatocellular carcinoma by urinary proteomics.
Zhao Y; Li Y; Liu W; Xing S; Wang D; Chen J; Sun L; Mu J; Liu W; Xing B; Sun W; He F
J Proteomics; 2020 Aug; 225():103780. PubMed ID: 32298775
[TBL] [Abstract][Full Text] [Related]
31. Global Meta-analysis of Urine Microbiome: Colonization of Polycyclic Aromatic Hydrocarbon-degrading Bacteria Among Bladder Cancer Patients.
Bukavina L; Isali I; Ginwala R; Sindhani M; Calaway A; Magee D; Miron B; Correa A; Kutikov A; Zibelman M; Ghannoum M; Retuerto M; Ponsky L; Markt S; Uzzo R; Abbosh P
Eur Urol Oncol; 2023 Apr; 6(2):190-203. PubMed ID: 36868921
[TBL] [Abstract][Full Text] [Related]
32. Plasma microRNA might as a potential biomarker for hepatocellular carcinoma and chronic liver disease screening.
Jiang L; Li X; Cheng Q; Zhang BH
Tumour Biol; 2015 Sep; 36(9):7167-74. PubMed ID: 25894380
[TBL] [Abstract][Full Text] [Related]
33. Understanding the Role of the Gut Microbiome and Microbial Metabolites in Non-Alcoholic Fatty Liver Disease: Current Evidence and Perspectives.
Vallianou N; Christodoulatos GS; Karampela I; Tsilingiris D; Magkos F; Stratigou T; Kounatidis D; Dalamaga M
Biomolecules; 2021 Dec; 12(1):. PubMed ID: 35053205
[TBL] [Abstract][Full Text] [Related]
34. Altered Gut Microbiota Composition and Its Potential Association in Patients with Advanced Hepatocellular Carcinoma.
Huo R; Chen Y; Li J; Xu Q; Guo J; Xu H; You Y; Zheng C; Chen Y
Curr Oncol; 2023 Feb; 30(2):1818-1830. PubMed ID: 36826102
[TBL] [Abstract][Full Text] [Related]
35. Comparison of the gut microbiota of short-term and long-term medical workers and non-medical controls: a cross-sectional analysis.
Zheng N; Li SH; Dong B; Sun W; Li HR; Zhang YL; Li P; Fang ZW; Chen CM; Han XY; Li B; Zhang SY; Xu M; Zhang GX; Xin Y; Ma YF; Wan XY; Yan QL
Clin Microbiol Infect; 2021 Sep; 27(9):1285-1292. PubMed ID: 33160036
[TBL] [Abstract][Full Text] [Related]
36. Alterations of nasal microbiome in eosinophilic chronic rhinosinusitis.
Liang Y; Xie R; Xiong X; Hu Z; Mao X; Wang X; Zhang J; Sun P; Yue Z; Wang W; Zhang G
J Allergy Clin Immunol; 2023 May; 151(5):1286-1295.e2. PubMed ID: 36736796
[TBL] [Abstract][Full Text] [Related]
37. Dysbiosis of the gut microbiome in elderly patients with hepatocellular carcinoma.
Zhang W; Xu X; Cai L; Cai X
Sci Rep; 2023 May; 13(1):7797. PubMed ID: 37179446
[TBL] [Abstract][Full Text] [Related]
38. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.
Colli A; Nadarevic T; Miletic D; Giljaca V; Fraquelli M; Štimac D; Casazza G
Cochrane Database Syst Rev; 2021 Apr; 4(4):CD013346. PubMed ID: 33855699
[TBL] [Abstract][Full Text] [Related]
39. Long noncoding RNA MyD88 functions as a promising diagnostic biomarker in hepatocellular carcinoma.
Wang Z; Gao P; Sun W; Rehman AU; Jiang J; Xu S; Xue C; Zhu C; Qin X
Front Endocrinol (Lausanne); 2023; 14():938102. PubMed ID: 36793272
[TBL] [Abstract][Full Text] [Related]
40. A Circulating Long Noncoding RNA Panel Serves as a Diagnostic Marker for Hepatocellular Carcinoma.
Huang J; Zheng Y; Xiao X; Liu C; Lin J; Zheng S; Yang B; Ou Q
Dis Markers; 2020; 2020():5417598. PubMed ID: 32733618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
